THÔNG TIN TÀI LIỆU
182 Agnoletti G, Ferraro G, Bordese R, et al Fontan circulation causes early, severe liver damage Should we offer patients a tailored strategy? Int J Cardiol 2016;209:60–65 183 Heyne K, Shin YS, Schwinger E Double heterozygosity (transferase-/epimerase-defect) and galactosemia cataract Monatsschr Kinderheilkd 1988;136(12):828–830 184 Wernovsky G, Lihn SL, Olen MM Creating a lesion-specific “roadmap” for ambulatory care following surgery for complex congenital cardiac disease Cardiol Young 2017;27(4):648– 662 185 Gewillig M, Goldberg DJ Failure of the fontan circulation Heart Fail Clin.2014;10(1):105– 116 186 Rychik J, Goldberg D, Rand E, et al End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis Cardiol Young 2013;23(6):831–840 187 Dori Y Novel lymphatic imaging techniques Tech Vasc Interv Radiol 2016;19(4):255–261 188 Itkin M, Piccoli DA, Nadolski G, et al Proteinlosing enteropathy in patients with congenital heart disease J Am Coll Cardiol 2017;69(24):2929–2937 189 Itkin MG, McCormack FX, Dori Y Diagnosis and treatment of lymphatic plastic bronchitis in adults using advanced lymphatic imaging and percutaneous embolization Ann Am Thorac Soc 2016;13(10):1689–1696 190 Ludwig J, Linhart P, Baggenstoss AH Hepatic lymph drainage in cirrhosis and congestive heart failure A postmortem lymphangiographic study Arch Pathol 1968;86(5):551–562 191 Avitabile CM, Goldberg DJ, Dodds K, et al A multifaceted approach to the management of plastic bronchitis after cavopulmonary palliation Ann Thorac Surg 2014;98(2):634– 640 192 Racz J, Mane G, Ford M, et al Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis airway casts Ann Am Thorac Soc.2013;10(2):98–107 193 Schumacher KR, Stringer KA, Donohue JE, et al Fontan-associated protein-losing enteropathy and plastic bronchitis J Pediatr 2015;166(4):970–977 194 Dori Y, Itkin M Etiology and new treatment options for patients with plastic bronchitis J Thorac Cardiovasc Surg 2016;152(2):e49–e50 195 Brooks K, Caruthers RL, Schumacher KR, Stringer KA Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease Pharmacotherapy 2013;33(9):922–934 196 Lubcke NL, Nussbaum VM, Schroth M Use of aerosolized tissue plasminogen activator in the treatment of plastic bronchitis Ann Pharmacother 2013;47(3):e13 197 Dori Y, Keller MS, Rome JJ, et al Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease Circulation 2016;133(12):1160–1170 198 Rychik J Protein-losing enteropathy after Fontan operation Congenit Heart Dis 2007;2:288–300 199 John AS, Johnson JA, Khan M, et al Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation J Am Coll Cardiol 2014;64(1):54–62 200 Mertens L, Hagler D, Sauer U, Somerville J, Gewillig M Protein-losing enteropathy after the Fontan operation: an international multicenter study PLE study group J Thorac Cardiovasc Surg 1998;115(5):1063–1073 201 Goldberg DJ, Dodds K, Avitabile CM, et al Children with protein-losing enteropathy after the Fontan operation are at risk for abnormal bone mineral density Pediatr Cardiol 2012;33(8):1264–1268 ... Brooks K, Caruthers RL, Schumacher KR, Stringer KA Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease Pharmacotherapy 2013;33(9):922–934 196 Lubcke NL, Nussbaum VM, Schroth M Use of
Ngày đăng: 22/10/2022, 12:15
Xem thêm: